Joan Chypyha

Joan Chypyha

Director of Finance/CFO at OVATION SCIENCE INC.

Net worth: 1 522 $ as of 29/09/2026

60 year
Health Technology
Consumer Services
Consumer Non-Durables

Profile

Ms. Joan Chypyha is an Independent Director at Edesa Biotech, Inc., a Chief Financial Officer & Director at Ovation Science, Inc. (Canada) and a President & Chief Executive Officer at Alto Pharmaceuticals Ltd. She is on the Board of Directors at Edesa Biotech, Inc. and Ovation Science, Inc. (Canada).
Ms. Chypyha was previously employed as a President by Canadian Dermatology Association, a President by Cipher Pharmaceuticals, Inc., a Chief Business Development Officer by Rhei Pharmaceuticals Ltd., and a VP-Corporate Development & General Manager by Barrier Therapeutics Canada, Inc. She also served on the board at Canadian Healthcare Licensing Association.
She received her undergraduate degree from the University of Toronto and an MBA from Queen's University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
19/10/2025 200,000 ( 0.52% ) 1 400 $ 29/09/2026
26/05/2026 29 ( 0% ) 122 $ 29/09/2026

Joan Chypyha active positions

CompaniesPositionStart
OVATION SCIENCE INC. Director of Finance/CFO 19/10/2026
EDESA BIOTECH, INC. Director/Board Member 22/05/2023
Chief Executive Officer 31/12/2007

Former positions of Joan Chypyha

CompaniesPositionEnd
President 31/12/2022
CIPHER PHARMACEUTICALS INC. President 01/06/2017
Rhei Pharmaceuticals Ltd.
Corporate Officer/Principal 31/12/2010
Barrier Therapeutics Canada, Inc.
Corporate Officer/Principal 31/07/2008
Canadian Healthcare Licensing Association
Director/Board Member -
See the detail of Joan Chypyha's experience

Education of Joan Chypyha

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

46

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Consumer Services

Consumer Services

Canadian Healthcare Licensing Association

Health Technology

Consumer Non-Durables

Rhei Pharmaceuticals Ltd.

Barrier Therapeutics Canada, Inc.

Health Technology

Commercial Services